Modulation of Emotion Perception in Humans Via Amygdala Stimulation
Neuromodulation of Affective Valence in Humans by Amygdala Stimulation
2 other identifiers
interventional
16
1 country
1
Brief Summary
This study will enroll patients with epilepsy who are being evaluated for epilepsy surgery and have intracranial EEG electrodes. In this study, the aim is to record brain signals from areas important in social and emotional processing and to understand how electrical brain stimulation - called neuromodulation - affects such processing. Patients enrolled in this study will be asked to view images depicting a variety of emotionally positive, negative, or neutral themes. As the patient views these images, a small amount of imperceptible and painless electric current will be used to map function of certain parts of a human brain. The overarching goal of the study is to determine if neuromodulation can be used in certain areas of the brain to treat cognitive disorders such as memory loss and post-traumatic stress disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2022
CompletedFirst Posted
Study publicly available on registry
March 23, 2022
CompletedStudy Start
First participant enrolled
March 31, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 16, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 16, 2024
CompletedResults Posted
Study results publicly available
September 22, 2025
CompletedSeptember 22, 2025
September 1, 2025
1.9 years
March 14, 2022
April 8, 2025
September 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Z-score Gamma Power in Amygdala Per Valence Category
Valence of each image is assessed by each subject using a Likert-type rating scale with a range of 1 to 7, where 1 represents most negative valence, 4 as neutral, and 7 as most positive. Valence categories are defined in the following manner: negative = 1.0 to 3.0, neutral = 3.1 to 5.0, negative = 5.1 to 7.0. Activation is measured by gamma frequency power (mµV²/30-100 Hz) at 0-1000 msec following image presentation in the basolateral amygdala electrode contact and compared to baseline defined as -500 msec to 0 of image presentation. Gamma power is transformed to z-score (baseline to following image presentation) for individual observations. Z-score of 0 indicates no change from baseline. Positive z-score indicates activation of the basolateral amygdala compared to baseline. Gamma frequency range is defined as 30-100 Hz in intracranial EEG. Power was estimated via a multitaper time-frequency transformation approach. Statistics was done using linear-mixed effects models (LMEs).
0 to 1000 MS following image presentation
Effect of Amygdala Stimulation on Perception of Valence
Here we assess the effect of basolateral amygdala stimulation on valence ratings. Participants rate the emotional valence of each image in a Likert scale range of 1-7 (1= maximum negative valence, 4=maximum neutral valence, and 7 maximum positive valence) for each of the 96 images. We randomly apply electrical stimulation during perception and of 50% of the images presented. We analyze the effect of stimulation on image rating in the following manner: we grouped the images into three categories, negative (1 to 3), neutral (3.1 to 5), and positive (5.1 to 7) based on subject specific ratings. 2. We then used a multivariate model to assess the effect of stimulation on perception of neutral, negative, and positive categories across 9 patients.
Valence ratings were assessed immediately following the viewing of each image during performance of the task.
Study Arms (2)
Stimulation
EXPERIMENTALThis part will include 24 randomly chosen images from each of four categories (total of 96 images varying in valence and arousal) and will be presented block-randomized amygdala stimulation.
No stimulation
NO INTERVENTIONThis part will include 24 randomly chosen images from each of four categories (total of 96 images varying in valence and arousal) and will be presented without amygdala stimulation.
Interventions
We will use a computer randomized stimulation of specific areas in the amygdala while showing a computer randomized set of pictures.
Eligibility Criteria
You may qualify if:
- Age of 18 years or older
- FSIQ 75 and above or any equivalent test of generalized intelligence as determined by the PI to adequately predict engagement in the task
- Able to give independent consent for participation in the study
You may not qualify if:
- Additional neurological disorders (such as dementia, stroke, brain tumor, etc.)
- Any psychiatric condition that would limit their ability to provide consent and/or perform study tasks within normal limits. This would be based on presurgical psychiatric assessment.
- Anything else, that in the opinion of the principal investigator, might preclude them from participating in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03776, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Krzysztof Bujarski
- Organization
- Dartmouth-Hitchcock Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Krzysztof A Bujarski, MD
Dartmouth-Hitchcock Medical Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Section Chief, Neurology
Study Record Dates
First Submitted
March 14, 2022
First Posted
March 23, 2022
Study Start
March 31, 2022
Primary Completion
February 16, 2024
Study Completion
February 16, 2024
Last Updated
September 22, 2025
Results First Posted
September 22, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
The study results will be available on ClinicalTrials.gov and will be published in appropriate clinical journal upon completion.